Elimination of mucosal cyathostome larvae by five daily treatments with fenbendazole.
The efficacy of five daily treatments with 7.5 mg fenbendazole/kg bodyweight against mucosal cyathostome larvae was evaluated in 20 12- and 24-month-old ponies with naturally acquired cyathostome infections. After three weeks communal grazing on infected pasture and six weeks indoors, one group of 10 ponies were treated. Six weeks later, both groups of ponies were humanely destroyed and their burdens of large intestinal cyathostome worms, including luminal parasites and mucosal larvae, were assessed. In the control animals approximately 7 per cent of the total worm burden was present in the gut lumen and 93 per cent was present as larvae in the large intestinal mucosa. The efficacy of fenbendazole against the luminal cyathostomes was 90.7 per cent (P < 0.01). The total numbers of mucosal larvae, recovered after digestion, were reduced by 95.3 per cent (P < 0.0005); mucosal late third and fourth stage larvae were reduced by 99.4 per cent (P < 0.0001), and early inhibited third stage larvae by 91.5 per cent (P < 0.005).
Duncan
J L
JL
Department of Veterinary Clinical Studies, University of Glasgow Veterinary School, Bearsden.
Bairden
K
K
Abbott
E M
EM
D000818:Animals; D000969:Antinematodal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D005273:Fenbendazole / Q000008:administration & dosage* / Q000627:therapeutic use; D006734:Horse Diseases / Q000188:drug therapy* / Q000469:parasitology; D006736:Horses; D007413:Intestinal Mucosa / Q000469:parasitology*; D010270:Parasite Egg Count; D010271:Parasites / Q000302:isolation & purification; D013319:Strongyle Infections, Equine / Q000188:drug therapy*; D013323:Strongylus / Q000469:parasitology; D016896:Treatment Outcome
D000969:Antinematodal Agents; D005273:Fenbendazole